| 2012 | 2,4-Diaryl-5,6-dihydro-1,10-phenanthroline and 2,4-diaryl-5,6- dihydrothieno[2,3-h] quinoline derivatives for topoisomerase i and II inhibitory activity, cytotoxicity, and structure-activity relationship study | 권영주 | Article |
| 2012 | A-62176, a potent topoisomerase inhibitor, inhibits the expression of human epidermal growth factor receptor 2 | 김대기; 권영주; 전규연 | Article |
| 2023 | Cannabidiol, a Regulator of Intracellular Calcium and Calpain | 권영주; 전경화 | Article |
| 2014 | Cobalt-albumin binding (CAB) assay: An advantageous and flaw free testing of albumin-cobalt binding | 권영주 | Article |
| 2012 | Dihydroxylated 2,4,6-triphenyl pyridines: Synthesis, topoisomerase i and II inhibitory activity, cytotoxicity, and structure-activity relationship study | 권영주 | Article |
| 2021 | Discovery of a 2,4-diphenyl-5,6-dihydrobenzo(h)quinolin-8-amine derivative as a novel DNA intercalating topoisomerase IIα poison | 권영주; 전경화; 황수연 | Article |
| 2013 | Dithiiranylmethyloxy azaxanthone shows potent anti-tumor activity via suppression of HER2 expression and HER2-mediated signals in HER2-overexpressing breast cancer cells | 권영주; 이윤실 | Article |
| 2013 | Expression and purification of a soluble ESX-binding core domain of sur2 | 권영주 | Article |
| 2018 | Hyperactivated m-calpain affects acquisition of doxorubicin resistance in breast cancer cells | 권영주 | Article |
| 2022 | Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors | 권영주; 전경화 | Article |
| 2023 | Interrupting specific hydrogen bonds between ELF3 and MED23 as an alternative drug resistance-free strategy for HER2-overexpressing cancers | 이화정; 권영주; 전경화; 황수연; 박서정 | Article |
| 2011 | Synthesis of 2,4-diaryl chromenopyridines and evaluation of their topoisomerase i and II inhibitory activity, cytotoxicity, and structure-activity relationship | 권영주 | Article |
